Opioids as growth regulators of normal and malignant immunohaematopoesis: A review

HAEMA

Volumn 7, Issue 3, 2004, Pages 287-295

  Martin Kleiner, Irena ^a   Gabrilovac, Jelka ^a   Boranić, Milivoj ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Cell growth; Cell proliferation; Cytokines; Hematopoiesis; HIV; Immune response; Immunohaematopoesis; Lymphatic tissue; Lymphocytes; Met enkephalin; Opioids

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; DELTORPHIN; DERMORPHIN; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DYNORPHIN; E 2087; ENDOMORPHIN 1; ENDORPHIN; ENKEPHALIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ETOMORPHIN; KAPPA OPIATE RECEPTOR; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; METENKEPHALIN; METENKEPHALIN[2 DEXTRO ALANINE]; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; NALTRINDOLE; NEUROTRANSMITTER; OPIATE; OPIATE PEPTIDE; OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR; SUFENTANIL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; CELL PROLIFERATION; CYTOKINE RELEASE; GROWTH REGULATION; HELPER CELL; HEMATOPOIESIS; HEMATOPOIETIC TISSUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOID TISSUE; PLEIOTROPY; PROTEIN BINDING; REVIEW;

EID: 4043064959     PISSN: 11082682     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Pleuvry BJ. Opioid receptors and their ligands: natural and unnatural. Br J Anaesth 1991; 66: 370-380.
2. Zadina JE, Hackler L, Ge L-J, Kastin AJ. A potent and selective endogenous agonist for the μ-opiate receptor. Nature 1997; 386: 499-502.
3. Dhawan BN, Cesselin F, Raghubir R et al. International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev 1996; 48: 567-592.
4. Sharp BM, Roy S, Bidlack JM. Evidence for opioid receptors on cells involved in host defence and the immune system. J Neuroimmunol 1998; 83: 45-56.
5. Plotnikoff NP, Faith RE, Murgo AJ et al. Methionine Enkephalin: A new cytokine-human studies. Clin Immunol Immunopathol 1997; 82: 93-101.
6. Bidlack JM. Detection and function of opioid receptors on cells from the immune system. Clin Diagn Lab Immunol 2000; 7: 719-723.
7. Simon EJ. Opioid receptors and endogenous opioid peptide. Med Res Rev 1991; 11: 357-374
8. Sharp BM, Shahabi NA, Heagy W et al. Dual signal transduction through delta opioid receptors in a transfected human T-cell line. Proc Natl Acad Sci USA 1996; 93: 8294-8299.
9. Lawrence DMP, Bidlack JM. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide binding regulatory protein. J Pharmacol Exp Ther 1993; 266: 1678-1683.
10. Martin-Kleiner I, Bidlack JM. Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and RIEGO leads to down-regulation of kappa opioid receptor without desensitization of adenylyl cyclase activity. Int Immunopharmacol 2001; 1: 13-20.
11. Martin-Kleiner I, Gabrilovac J. The κ-opioid agonist U-69593 affects intracellular calcium level in R1.1 mouse thymoma cell line. Int Immunopharmacol 2002; 2: 975-980.
12. Martin-Kleiner I, Osmak M, Gabrilovac J. Regulation of NK cell Activity and the level of the intracellular cAMP in human peripheral blood lymphocytes by Metenkephalin. Res Exp Med 1992; 192: 145-150.
13. Sorensen AN, Claesson MH. Effect of the opioid methionine enkephalinamide on signal transduction in human T-lymphocytes. Life Sci 1998; 62: 1251-1259.
14. Martin-Kleiner I, Gabrilovac J. The effect of δ-opioid agonists on intracellular calcium level in MOLT-4 T-cell line. Int J Immunopathol Pharmacol 1999; 12: 113-119.
15. Liu XH, Huang DA, Yang FY et al. A new cytokine: the possible effect of pahtway of methionine enkephalin. World J Gastroenterol 2003; 15: 169-173.
16. Heagy W, Teng E, Lopez P, Finberg RW. Enkephalin receptors and receptor-mediated signal transduction in cultured human lymphocytes. Cell Immunol 1999; 191: 34-48.
17. Martin-Kleiner I, Gabrilovac J. Increase of intracellular cAMP level in human peripheral blood mononuclear cells by Met-enkephalin. Acta Pharm. 1997; 47: 9-14.
18. 2+ modulation in human B cell lines. J Immunol 1992; 149: 4074-4081.
19. Haberstok H, Marotti T, Banfić H. Neutrophil signal transduction in Met-enkephalin modulated superoxide anion release. Neuropeptides 1996; 30: 193-201.
20. Kamphuis S, Kavelaars A, Brooimans R et al. T helper 2 cytokines induce preproenkephalin mRNA expression and proenkephalin A in human peripheral blood mononuclear cells. J Neuroimmunol 1997; 79: 91-99.
21. Kamphuis S, Eriksson F, Kavelaars F et al. Role of endogenous pro-enkephalin A-derived peptides in human T cell proliferation and monocyte IL-6 production. J Neuroimmunol 1998; 84: 53-60.
22. Cabot PJ, Carter L, Schafer M, Stein C. Methionine-enkephalin and dynorphin A-release from immune cells and control of inflammatory pain. Pain 2001; 93: 207-212.
23. Jessop DS, Major GN, Coventry TL et al. Novel opioid peptides endomorphin-1 and endomorhin-2 are present in mammalian immune tissues. J Neuroimmunol 2000; 106: 53-59.
24. Marotti T, Rabatić S, Gabrilovac J. A characterization of the in vivo immunomodulation by Met-enkephalin in mice. Int J Immunopharmacol 1993; 15: 919-926.
25. Linner KM, Quist HE, Sharp BM. Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation. J Immunol 1995; 154: 5049-5060.
26. Krizanac-Bengez LJ, Breljak D, Boranic M. Suppressive effect of Met-enkephalin on bone marrow cell proliferation in vitro shows circardian pattern and depends on the presence of adherent accessory cells. Biomed Pharmacother 1996; 50: 85-91.
27. Boranić M. While waiting for Christopher Columbus to discover alternative route(s) of bone marrow regulation, keep faith the body is a global system. Exp Hematology 1998; 26: 1018-1019.
28. Breljak D, Boranić M, Horvat S. Oligopeptide fragments of the enkephalin molecule interfere with hematopoetic cell colony formation. Int J Immunopathol Pharmacol 2000; 13: 13-19.
29. Dubinin KV, Zakharova LA, Khegai LA, Zaitsev SV. Immunomodulating effect of Met-enkephalin on different stages of lymphocyte proliferation induced with Concanavalin A in vitro. Immunopharmacol Immunotoxicol 1994; 16: 463-472.
30. Hucklebridge FH, Hudspith BN, Muhamed J et al. Methionine-enkephalin stimulates in vitro proliferation of human peripheral lymphocytes via delta-opioid receptors. Brain Behav Immun 1989; 3: 183-189.
31. Štambuk N, Kopjar N, Šentija K et al. Cytogenetic effects of Met-enkephalin (Peptid-M) on human lymphocytes. Croat Chem Acta 1998; 71: 591-605.
32. Gabrilovac J, Marotti T. Gender-related differencies in murine T- and B-lymphocyte proliferative ability in response to in vivo Met(5)enkephalin administration. Eur J Pharmacol 2000; 392: 101-108.
33. Kharkevich DD, Kadaigdze ZG. The effect of the stimulation of opioid receptors on lymphocyte functional activity in vivo. Biul Eksp Biol Med. 1989; 108: 315-316.
34. + murine T cells. J Pharmacol Exp Ther 1995; 273: 1105-1113.
35. Eisenstein TK, Hilburger ME. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell population. J Neuroimmunol 1998; 83: 36-44.
36. Caroleo MC, Arbitrio M, Melchiorri D, Nistico G. A reappraisal of the role of the various opioid receptor subtypes in cell-mediated immunity. Neuroimmunomodulation 1994; 1: 141-147.
37. Brown SL, Van Epps DE. Opioid peptides modulate production of interferon γ by human mononuclear cells. Cell Immunol 1986; 103: 19-26.
38. Gabrilovac J, Ikić-Sutlić M, Knežević N, Poljak L. Leuenkephalin enhances interferon secretion in mice. Res Exp Med 1996; 196: 137-144.
39. Apte RN, Durum SK, Oppenheim JJ. Opioids modulate interleukin-1 production and secretion by bone-marrow macrophages. Immunol Lett 1990; 24: 141-148.
40. Marotti T, Burek B, Rabatić S, Balog T, Hršak I. Modulation of lipopolysaccharide-induced production of cytokines by Methionine-enkephalin. Immunol Lett 1994; 40: 43-47.
41. Kowalski J, Makowiecka K, Belowski D, Herman ZS. Augmenting effect of methionine-enkephalin on interleukin-6 production by cytokine-stimulated murine macrophages. Neuropeptides 2000; 34: 187-192.
42. Singh S, Singh PP, Dhawan VC et al. Lymphokines production by Concanavalin A-stimulated mouse splenocytes-modulation by Met-enkephalin and a related peptide. Immmunopharmacol 1994; 27: 245-251.
43. Narayan P, Tandon R, Haq W et al. Inhibition of antigen specific lymphocyte proliferation and cytokine stimulation by peptidomimetic opioid compound. Int Immunopharmacol 2002; 2: 751-757.
44. House RV, Thomas PT, Bhargava HN. A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides. Peptides 1996; 17: 75-81.
45. Noviello L, Papadia S, Capobianchi MR, Negri L. Immunomodulatory responses to delta-opioid receptor ligands in human lymphocytes. Europ J Pharmacol 1997; 332: R1-R2.
46. Guan L, Eisenstein TK, Adler MW, Rogers TJ. Inhibition of T cell superantigen responses following treatment with the kappa-opioid agonist U50,488H. J Neuroimmunol 1997; 75: 163-168.
47. Belkowski SM, Alicea C, Eisenstein TK et al. Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50,488. J Pharmacol Exp Ther 1995; 273: 1491-1496.
48. Eisenstein TK, Bussiere JL, Rogers TJ, Adler MW. Immunosppressive effects of morphine on immune responses in mice. Adv Exp Med 1993; 335: 41-52.
49. Jessop JJ, Taplits MS. Effect of high doses of morphine on Con-A induced lymphokine production. Immunopharmacol 1991; 22: 175-184.
50. Roy S, Balasubramanian S, Sumandeep S et al. Morphine directs T cell toward T-H2 differentiation. Sugery 2001; 130: 304-309.
51. Roy S, Barke RA, Loh HH. MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions. Mol Brain Res 1998; 61: 190-194.
52. Roy S, Ramakrishnan S, Loh HH, Lee NM. Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow. Europ J Pharmacol 1991; 195: 359-363.
53. Peng XH, Mosser DM, Adler MW et al. Morphine enhances interleukin-12 and the production of other proinflammatory cytokines in mouse peritoneal macrophages. J Leukoc Biology 2000; 68: 723-728.
54. Azuma Y, Ohura K. Endomorphin 1 and 2 inhibit IL-10 and IL-12 production and innate immune functions, and potentiate NF-kappa B DNA binding in THP-1 differentiated to macrophage-like cells. Scand J Immunol 2002; 56: 260-269.
55. Azuma Y, Ohura K. Endomorphin-2 modulates production of TNF-alpha IL-1 beta, IL-10, and IL-12 and alters functions related to innate immune of macrophages. Inflammation 2002; 26: 223-232.
56. Zagon IS, Roesener CD, Verderame MF et al. Opioid growth factor regulates the cell cycle of human neoplasias. Int J Oncol 2000; 17: 1053-1061.
57. Zagon IS, Smith JP, McLaughlin PJ. Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid proliferation factor. Int J Oncol 1999; 14: 577-584.
58. Bisignani GJ, McLaughlin PJ, Ordille SD et al. Human renal cell cancer proliferation in tissue culture is tonically inhibited by opioid proliferation factor. J Urology 1999; 162: 2186-2191.
59. Levin RJ, Wu Y, McLaughlin PJ, Zagon IS. Expression of the opioid proliferation factor, [Met5]-enkephalin and zeta opioid receptor in head and neck squamous cell carcinoma. Laryngoscope 1997; 107: 335-339.
60. Zagon IS, Verderame MF, McLaughlin PJ. The biology of the opioid proliferation factor receptor (OGFr). Brain Res Rev 2002; 38: 351-376.
61. McLaughlim PJ, Stack BC, Levin RJ et al. Defects in the opioid growth factor receptor in human squamous cell carcinoma of the head and the neck. Cancer 2003; 97: 1701-1710.
62. Martin-Kleiner I, Gabrilovac J, Kušec R, Boranić M. Methionine-enkephalin suppresses metabolic activity of a leukemic cell line (NALM-1) and enhances CD10 expression. Int Immunopharmacol 2003; 3: 707-711.
63. Martin-Kleiner I. The effect of opioid agonists of delta-class DSLET, mu-class DAMGO, kappa-class U-69593 and an opioid antagonist, naloxone, on MTT activity of NALM-1 leukemic cells. Biomed Pharmacother 2002; 56: 458-462.
64. Maneckjee R, Biswas R, Vonderhaar BK. Binding of opioids to human MCF-7 breast cancer cell and their effects on proliferation. Cancer Res 1990; 50: 2234-2238.
65. Venihaki M, Gravanis A, Margioris AN. Kappa opioids exert a strong antiproliferative effect on PC12 rat pheochromocytoma cells. Peptides 1996; 17: 413-419.
66. Sueoka N, Sueoka E, Okabe S, Fujiki H. Anti-cancer effects of morphine through inhibition of tumor necrosis factor-alpha release and mRNA expression. Carcinogenesis 1996; 17: 2337-2341.
67. Mernenko OA, Blishchenko EY, Mirkina II, Karelin AA. Met-enkephalin induces cytolytic process of apoptotic type in K-562 human erythroid leukemia cells. FEBS Lett 1996; 383: 230-232.
68. Balog T, Marotti T, Musani V et al. The effect of methionine-enkephalin on nitric oxide release in mice is age and gender related. Pharmacol Res 2001; 44: 287-292.
69. Diao CTM, Li L, Lau SY et al. kappa-opioid receptor potentiates apoptosis via a phospholipase C pathway in the CNE2 human epithelial tumor cell line. Bioch Biophys Acta - Mol Cell Res 2000; 1499: 49-62.
70. Wang J, Charboneau R, Balasubramanian S et al. Morphine modulates lymph node-derived T lymphocyte function: role of caspase-3, -8, and nitric oxide. J Leukoc Biology 2001; 70: 527-536
71. Sueoka E, Sueoka N, Kai Y et al. Anticancer activity of morphine and its synthetic derivative KT-90, mediated through apoptosis and inhibition of NF-kappa B activation. Biochem Biophys Res Commun 1998; 252: 566-570.
72. Hatsukari I, Hitosugi N, Matsumoto I et al. Induction of early apoptosis marker by morphine in human lung and breast carcinoma cell lines. Anticancer Res 2003; 23: 2413-2417.
73. Sharp BM, Gekker G, Li MD et al. Delta-opioid suppression of human immunodeficiency Virus-1 expression in T cells (JURKAT). Biochem Pharmacol 1998; 56: 289-292.
74. + lymphocytes. Biochem Pharmacol 2001; 61: 1145-1151.
75. Chao CC, Gekkker G, Hu SS et al. Kappa-opioid potentiation of tumor necrosis factor alpha-induced anti-HIV activity in acutely infected human brain cell cultures. Biochem Pharmacol 1998; 56: 397-404.
76. Lokensgard JR, Gekker G, Peterson PK. Kappa-opioid receptor agonist inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion and CXCR4 expression on CD4 (+) lymphocytes. Biochem Pharmacol 2002; 63: 1037-1041.
77. Peterson PK, Sharp BM, Gekker G et al. Morphine promotes the growth of HIV-1 in human periheral blood mononuclear cell cocultures. AIDS 1990; 4: 869-873.
78. Chao CC, Hu S, Molitor TW et al. Morphine potentiates transforming growth factor-beta release from human peripheral blood mononuclear cell cultures. J Pharmacol Exp Ther 1992; 262: 19-24.
79. Nyland SB, Cao CH, Bai Y et al. Modulation of infection and type 1 cytokine expression parameters by morphine during in vitro coinfection with human T-cell leukemia and virus type I and HIV-1. J Acquir Immune Defic Syndr 2003; 32: 406-416.